These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6151117)

  • 1. Affinities of some common opioid analgesics towards four binding sites in mouse brain.
    Neil A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):24-9. PubMed ID: 6151117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid ligand binding sites in the spinal cord of the guinea-pig.
    Zarr GD; Werling LL; Brown SR; Cox BM
    Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of four binding sites for opioids in the mouse brain.
    Neil A
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):108-16. PubMed ID: 2986409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
    Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP; Kwiat G; Lee NM
    Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
    Ramme D; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different types of opiate agonists interact distinguishably with mu, delta and kappa opiate binding sites.
    Pfeiffer A; Herz A
    Life Sci; 1982 Sep 20-27; 31(12-13):1355-8. PubMed ID: 6128658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of codeine-7,8-oxide (codeine-epoxide), as a new metabolite of codeine, with multiple opiate receptors.
    Konno F; Sato Y; Togashi K; Takayanagi I; Hirobe M
    Gen Pharmacol; 1985; 16(4):379-81. PubMed ID: 2995195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa).
    Spain JW; Roth BL; Coscia CJ
    J Neurosci; 1985 Mar; 5(3):584-8. PubMed ID: 2983043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N; Pasternak GW
    Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Hepp J; Khan A; Borsodi A; Szücs M; Medzihradszky K; Wollemann M
    Neuropeptides; 1987 Jul; 10(1):19-28. PubMed ID: 2890119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord.
    Mack KJ; Killian A; Weyhenmeyer JA
    Life Sci; 1984 Jan; 34(3):281-5. PubMed ID: 6319937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid control of the ruminant stomach motility: functional importance of mu, kappa and delta receptors.
    Ruckebusch Y; Bardon T; Pairet M
    Life Sci; 1984 Oct; 35(17):1731-8. PubMed ID: 6090847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]U69,593 binding in guinea-pig brain: comparison with [3H]ethylketazocine binding at the kappa-opioid sites.
    Tiberi M; Payette P; Mongeau R; Magnan J
    Can J Physiol Pharmacol; 1988 Nov; 66(11):1368-72. PubMed ID: 2853991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.